Page last updated: 2024-08-23

bromocriptine and Fibrous Dysplasia, Polyostotic

bromocriptine has been researched along with Fibrous Dysplasia, Polyostotic in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (28.57)	18.7374
1990's	5 (71.43)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alaghband-Zadeh, J; Chung, KF; Guz, A	1
Chanson, P; Derome, PJ; Dib, A; Visot, A	1
Cavanah, SF; Dons, RF	1
Chiarini, V; Cremonini, N; Graziano, E; Sforza, A; Zampa, GA	1
Ladenson, PW; Sherman, SI	1
Abs, R; Beckers, A; De Schepper, A; Hennen, G; Stevenaert, A; Van de Vyver, FL	1
Hirooka, M; Itoh, M; Nagasaka, A; Nakagawa, H; Nakagawa, K; Nakai, A; Nihei, N; Ohyama, T; Sugiura, T; Yabe, Y	1

Reviews

1 review(s) available for bromocriptine and Fibrous Dysplasia, Polyostotic

Article	Year
McCune-Albright syndrome: how many endocrinopathies can one patient have? Southern medical journal, 1993, Volume: 86, Issue:3 Topics: Bromocriptine; Female; Fibrous Dysplasia, Polyostotic; Heart Failure; Humans; Hyperparathyroidism; Hyperprolactinemia; Hyperthyroidism; Iodine Radioisotopes; Middle Aged; Puberty, Precocious; Radiography	1993

Other Studies

6 other study(ies) available for bromocriptine and Fibrous Dysplasia, Polyostotic

Article	Year
Acromegaly and hyperprolactinemia in McCune-Albright syndrome. Evidence of hypothalamic dysfunction. American journal of diseases of children (1960), 1983, Volume: 137, Issue:2 Topics: Acromegaly; Bromocriptine; Child; Female; Fibrous Dysplasia of Bone; Fibrous Dysplasia, Polyostotic; Follicle Stimulating Hormone; Growth Hormone; Humans; Hypopituitarism; Hypothalamus; Luteinizing Hormone; Pituitary Neoplasms; Prolactin; Thyrotropin-Releasing Hormone	1983
McCune-Albright syndrome and acromegaly: clinical studies and responses to treatment in five cases. European journal of endocrinology, 1994, Volume: 131, Issue:3 Topics: Acromegaly; Adenoma; Adolescent; Adult; Bromocriptine; Female; Fibrous Dysplasia, Polyostotic; Growth Hormone; Humans; Magnetic Resonance Imaging; Male; Octreotide; Pituitary Neoplasms; Thyrotropin-Releasing Hormone	1994
Atypical McCune-Albright syndrome associated with growth hormone-prolactin pituitary adenoma: natural history, long-term follow-up, and SMS 201-995--bromocriptine combined treatment results. The Journal of clinical endocrinology and metabolism, 1992, Volume: 75, Issue:4 Topics: Acromegaly; Adenoma; Adult; Bromocriptine; Drug Therapy, Combination; Female; Fibrous Dysplasia, Polyostotic; Growth Hormone; Humans; Hyperprolactinemia; Octreotide; Pituitary Neoplasms	1992
Octreotide therapy of growth hormone excess in the McCune-Albright syndrome. Journal of endocrinological investigation, 1992, Volume: 15, Issue:3 Topics: Bromocriptine; Fibrous Dysplasia, Polyostotic; Growth Hormone; Humans; Male; Middle Aged; Octreotide; Pituitary Function Tests	1992
Acromegaly, multinodular goiter and silent polyostotic fibrous dysplasia. A variant of the McCune-Albright syndrome. Journal of endocrinological investigation, 1990, Volume: 13, Issue:8 Topics: Acromegaly; Adenoma; Adult; Brain; Bromocriptine; Female; Fibrous Dysplasia, Polyostotic; Goiter; Growth Hormone; Humans; Magnetic Resonance Imaging; Menstruation Disturbances; Octreotide; Pituitary Neoplasms; Prolactin	1990
Gigantism associated with McCune-Albright's syndrome. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1985, Volume: 17, Issue:10 Topics: Adolescent; Bromocriptine; Fibrous Dysplasia of Bone; Fibrous Dysplasia, Polyostotic; Gigantism; Growth Hormone; Humans; Levodopa; Male; Radiography; Radionuclide Imaging; Thyrotropin-Releasing Hormone	1985